Augusta University
 |
|
 |
Satyanarayana Ande, PhD
Molecular Oncology and Biomarkers |
 |
Michael Benedict, PharmD Associate Director of Administration |
 |
Department of Radiology
|
 |
Department of Radiation Oncology
|
 |
Hasan Korkaya, DVM, PhD Molecular Oncology and Biomarkers |
 |
Nita J. Maihle, PhD Associate Director for Education |
 |
Frank Mott, MD Head and Neck |
 |
Bioinformatics, Biostatistics and Computational Biology
|
 |
Huda Salman, MD, Hematology/Oncology |
 |
Claude Sportès, MD, Bone Marrow Transplant |
The GRU Cancer Center is thrilled to launch its internal newsletter, the CC:Report. The GRU Cancer Center Communications Team hopes you enjoy this premier issue and find it to be a helpful tool to assist, connect, and encourage you in your endeavors at the Cancer Center. Please contact Lisa Middleton (lmiddleton@gru.edu; x.14566) if you have information you would like to be considered for future editions.
A Time of growth and Change
“They always say time changes everything, but you actually have to change them yourself.”
– Andy Warhol
The GRU Cancer Center is undergoing an intense period of change. New staff, scientists and faculty have arrived. Others have departed. Growth is happening at an astonishing rate and the work we do and way we do it is evolving with each passing day. It’s an exciting time and an exciting process to be part of. And this is only the beginning. Read more >>
- Ghamande Leads Physician Outreach Efforts
- Tobacco Cessation Program Kicks-off
- GRU Cancer Center Lecture Series Offers CME Credits
- We’ve Got a New Face(book)
Researcher’s Toolkit
- Postmenopausal Women, Obesity, and Breast Cancer Risk
Using a simple urine test, researchers have identified a biomarker that may correlate with breast cancer risk in postmenopausal women. Read more >>
- Leukemia/Lymphoma – Toward a Better Prognosis
GRU Cancer Center researchers have identified a potential treatment strategy for a rare but aggressive, largely incurable type of leukemia/lymphoma that is resistant to all current therapies. Read more >>
- Improving Cancer Immunotherapy
Researchers at the GRU Cancer Center have discovered a way to give the immune system a boost in its ability to recognize tumor cells as “enemy” agents. Read more >>
Extramural
- Satyanarayana Ande, PhD, received a $439K, 3-year K22 grant from NCI/NIH for “Role of Id1 in adiposity, energy balance and obesity associated liver tumorigenesis.” Read more >>
- Andrew Mellor, PhD, received a $1.5M, 4-year R01 grant from NIAID/NIH for “Engineering DNA nanoparticles to create immune tolerance.” Read more >>
- Martha S. Tingen, PhD and Christine O’Meara, MA, MPH, received a $10K Wellness Mini-Grant from the University System of Georgia for “Promoting Wellness through Tobacco Cessation: A Component of the Tobacco-Free Campus Initiative at Georgia Regents University (GRU).” Read more >>
- Internal Translational Research Award Winners Read more >>
- Olivier Rixe, PhD, MD: “Effect of 14-day repeated oral doses (500 mg) of SAR302503 on ventricular repolarization, compared to 1-day placebo, in adult patients with advanced solid tumors.” Read more >>
- Shefali Shah, MD: “A Phase II study of docetaxel in combination with 1-methyl-D-tryptophan (indoximod) in metastic breast cancer.” Read more >>